2018
DOI: 10.1002/chem.201801090
|View full text |Cite
|
Sign up to set email alerts
|

Organometallic Conjugates of the Drug Sulfadoxine for Combatting Antimicrobial Resistance

Abstract: Fourteen novel arene Ru , and cyclopentadienyl (Cp ) Rh and Ir complexes containing an N,N'-chelated pyridylimino- or quinolylimino ligand functionalized with the antimalarial drug sulfadoxine have been synthesized and characterized, including three by X-ray crystallography. The rhodium and iridium complexes exhibited potent antiplasmodial activity with IC values of 0.10-2.0 μm in either all, or one of the three Plasmodium falciparum assays (3D7 chloroquine sensitive, Dd2 chloroquine resistant and NF54 sexual … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
35
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 30 publications
(35 citation statements)
references
References 64 publications
0
35
0
Order By: Relevance
“…Most notably, complexation with the IrCp* moiety has been shown to restore the potency of antimalarial drugs that have experienced total clinical resistance. Chellan and colleagues demonstrated this upon their exploration of NˆN-chelated iridium analogues of the clinical antimalarial drug, sulfadoxine (21), which is facing full resistance by P. falciparum strains ( Figure 5) [30]. This group synthesized a series of N,N -chelate pyridylimino- (22) or quinolylimino-(23) IrCp* complexes, functionalized with sulfadoxine ( Figure 5), and evaluated their antiplasmodial activity against P. falciparum strains.…”
Section: Sulfadoxine Ligandsmentioning
confidence: 99%
See 2 more Smart Citations
“…Most notably, complexation with the IrCp* moiety has been shown to restore the potency of antimalarial drugs that have experienced total clinical resistance. Chellan and colleagues demonstrated this upon their exploration of NˆN-chelated iridium analogues of the clinical antimalarial drug, sulfadoxine (21), which is facing full resistance by P. falciparum strains ( Figure 5) [30]. This group synthesized a series of N,N -chelate pyridylimino- (22) or quinolylimino-(23) IrCp* complexes, functionalized with sulfadoxine ( Figure 5), and evaluated their antiplasmodial activity against P. falciparum strains.…”
Section: Sulfadoxine Ligandsmentioning
confidence: 99%
“…Interrogation of complexation effects and influence of substitution effects on the benzene ring revealed similar SAR trends as the iridium derivatives (7-10) previously discussed. Likewise, Chellan et al also studied the antiplasmodial potency of the rhodium(III) counterparts (63-64) of the organometallic iridium(III) pyridyl-and isoquinolyl-sulfadoxine conjugates (22-23, Figure 5) against CQS 3D7 and NF54 strains, as well as resistant Dd2 parasites, which generally displayed a significant improvement in activity relative to the Ir(III) complexes across all strains ( Figure 15) [30]. Again, the generated SAR trends were similar for both types of complexes, as discussed earlier.…”
Section: Quinoline-salicylaldiminato and Sulfadoxine Ligandsmentioning
confidence: 99%
See 1 more Smart Citation
“…Several ruthenium complexes containing the 2-pyridinecarboxylic acid anion (picolinate) already demonstrated potential anti-Tb activity [109,110]; more recently, novel arene Ru, cyclopentadienyl (Cpx) Rh and Ir complexes containing an N,N'-chelated pyridylimino or quinolylimino ligand functionalized with the sulfadoxine were tested: in these complexes, the imino and pyridyl/quinolyl nitrogens provided an N,N-chelation site for the metal and exhibited potent antiplasmodial activity with IC 50 values in the low micromolar range. An increase in the size of both the Cpx ligand and the aromatic imino substituent increased hydrophobicity and antiplasmodial activity [111].…”
Section: Antibiotic Metal Complexes In Mtb Treatmentmentioning
confidence: 99%
“…Interest in metal based antimicrobial agents is growing, though many of the recent reports feature complexes of metals with organic molecules that are already known to have antimicrobial properties. [20][21][22] Indeed, a new edition of "Metals in Medicine" has a larger section on antimicrobials than did the previous edition, but there still, the bulk of the section deals with complexes of known drugs. 23 Lately, we have reported on a class of what are known as "halfsandwich" metal complexes that can be tuned for activity against mycobacteria 24,25 as well as against S. aureus including MRSA.…”
Section: Drug Resistance: a Serious Threatmentioning
confidence: 99%